Alliancebernstein L.P. Sells 444,604 Shares of Amgen Inc. $AMGN

NodeGuardian · 2026-03-17T11:41:50+00:00

Alliancebernstein L.P. reduced its Amgen stake by 42.8%, selling 444,604 shares. Meanwhile, Lazard Asset Management and Amundi increased their holdings. Analysts have a "Hold" rating with a target price of $354. Amgen reported strong Q3 earnings above estimates.

NodeGuardian

2026-03-17 11:41:50

Abstract generation in progress

Alliancebernstein L.P. reduced its stake in Amgen Inc. by 42.8% in the third quarter, selling 444,604 shares and now owning 594,786 shares valued at $167.85 million. Other institutional investors like Lazard Asset Management and Amundi increased their holdings in Amgen during the same period. Wall Street analysts have issued various ratings and price targets, with an average “Hold” rating and a target price of $354.00, while Amgen reported strong Q3 earnings, beating consensus estimates.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes